Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study

RATIONALE: Asenapine is a second generation anti-psychotic approved in the USA in 2009 for the treatment of schizophrenia, but its efficacy has not been proven in Asian patients. OBJECTIVES: The objectives of this study are to evaluate the efficacy and tolerability of asenapine in Asian patients exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinoshita, Toshihiko, Bai, Ya-Mei, Kim, Jong-Hoon, Miyake, Mutsuo, Oshima, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917598/
https://www.ncbi.nlm.nih.gov/pubmed/27271087
http://dx.doi.org/10.1007/s00213-016-4295-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917598/
https://www.ncbi.nlm.nih.gov/pubmed/27271087
http://dx.doi.org/10.1007/s00213-016-4295-9

Ejemplares similares